Gender-affirming care may reduce the risk of HIV among trans, nonbinary and gender-diverse people
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...
Open Access Government12h
Global HIV response: Study warns of setbacks in HIV fight due to funding cuts
A recent study published in The Lancet HIV, conducted by the Burnet Institute and WHO, showed a critical issue regarding ...
News-Medical.Net21h
Gender affirming hormone therapy reduces HIV risk for transgender people
Transgender people receiving gender-affirming hormone therapy have a 37% lower chance of acquiring HIV, and for people living with HIV, hormone therapy appears to offer a 44% lower chance of the virus ...